According to GO enrichment gene function, a total of six potential targets of NAT10 in DLBCL were identified, including SLC30A9, CREB5, TIMP1, MUC16, LIG3 and WNT10A (Figure 4F). This evidence concerns the gene WNT10A and diffuse large B-cell lymphoma.